Water → N-(3-fluoro-4-methylphenyl)-7-({2-[(methylamino)carbonyl]-pyridin-4-yl}oxy)-3,4-dihydroisoquinoline-2(1H)-carboxamide

HRID 1640224ノート

反応式

HRID 1640224 の反応式
[CH3:1][NH:2][C:3]([C:5]1[CH:10]=[C:9]([O:11][C:12]2[CH:21]=[C:20]3[C:15]([CH2:16][CH2:17][NH:18][CH2:19]3)=[CH:14][CH:13]=2)[CH:8]=[CH:7][N:6]=1)=[O:4].[F:22][C:23]1[CH:28]=[C:27]([N:29]=[C:30]=[O:31])[CH:26]=[CH:25][C:24]=1[CH3:32].O>CN(C=O)C>[F:22][C:23]1[CH:28]=[C:27]([NH:29][C:30]([N:18]2[CH2:17][CH2:16][C:15]3[C:20](=[CH:21][C:12]([O:11][C:9]4[CH:8]=[CH:7][N:6]=[C:5]([C:3]([NH:2][CH3:1])=[O:4])[CH:10]=4)=[CH:13][CH:14]=3)[CH2:19]2)=[O:31])[CH:26]=[CH:25][C:24]=1[CH3:32]

参加物

5

実験手順

To a solution of N-methyl-4-(1,2,3,4-tetrahydroisoquinolin-7-yloxy)pyridine-2-carboxamide (34 mg, 0.12 mmol) in DMF (1 mL) was added to 2-fluoro-4isocyanato-1-methylbenzene (21.8 mg, 0.144 mmol). The reaction mixture was allowed to stir for 24 h. Water added and the resulting solid was separated and purified by reverse phase HPLC to N-(3-fluoro-4-methylphenyl)-7-({2-[(methylamino)carbonyl]-pyridin-4-yl}oxy)-3,4-dihydroisoquinoline-2(1H)-carboxamide (32 mg, 61%). LCMS: (AA) ES+) 435.5.

後処理

  1. customthe resulting solid was separated
  2. custompurified by reverse phase HPLC to N-(3-fluoro-4-methylphenyl)-7-({2-[(methylamino)carbonyl]-pyridin-4-yl}oxy)-3,4-dihydroisoquinoline-2(1H)-carboxamide (32 mg, 61%)

出典と根拠

ORDレコード
ord-92b88351ad104bc393954680d611d3a8
出典データセット
uspto-grants-2012_02
特許番号
US08110687B2

反応ノート

読み込み中…